Immunic Has Received A Notice Of Allowance From United States Patent And Trademark Office For Patent Covering Composition-Of-Matter Of Vidofludimus Calcium (IMU-838) And Related Production Method, Expected To Provide Protection Into 2039
Immunic已收到美國專利商標局批准的專利通知,該專利涵蓋了Vidofludimus Calcium的物質成分和相關生產方法,預計將在2039年之前提供保護 IMU-838